The event is a conference call for investors and analysts to discuss the company's unaudited financial results for Q2 and H1FY27 (Quarter and Half Year ended 30 September 2026).
The conference call is scheduled for Friday, 6 November 2026 at 6:30 PM IST.
The results will be announced earlier on the same day, and the call will begin with a brief management discussion followed by an interactive Q&A session.
The senior management of Cohance Lifesciences Ltd. will participate in the call.
The document does not indicate that any presentation, earnings deck, transcript, or recording will be made available.
The document contains standard compliance language as a regulatory filing but does not explicitly state that no unpublished price sensitive information (UPSI) will be shared.
Additional Notes Section
The document includes detailed dial-in numbers for participants in India, Singapore, Hong Kong, USA, and UK.
Pre-registration is required via a provided link to receive dial-in numbers, a passcode, and a pin.
No financial data, guidance references, or strategic themes are disclosed in this announcement.
Investor relations contacts are provided: Cyndrella Carvalho (Head - Investor Relations, Cohance Lifesciences) and Gavin Desa / Konpal Pali (CDR India).
